Publications by authors named "Susan Lovick"

Claim this Profile
S
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT).
Richard D Carvajal, Sophie Piperno-Neumann, Ellen Kapiteijn, Paul B Chapman, Stephen Frank, Susan Lovick

J Clin Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and pharmacogenetics of the MEK1/2 inhibitor, selumetinib, in Asian and Western healthy subjects: a pooled analysis.
Angela W Dymond, Cathy Elks, Paul Martin, David J Carlile, Gabriella Mariani, Susan Lovick

Eur J Clin Pharmacol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data Science Solution to Event Prediction in Outsourced Clinical Trial Models.
Daniel Dalevi, Susan Lovick, Helen Mann, Paul D Metcalfe, Stuart Spencer

Stud Health Technol Inform· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of renal biomarkers for use in clinical trials: biomarker evaluation in healthy volunteers.
David A Brott, Scott H Adler, Ramin Arani, Susan C Lovick, Mark Pinches

Drug Des Devel Ther· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vandetanib inhibits both VEGFR-2 and EGFR signalling at clinically relevant drug levels in preclinical models of human cancer.
Sandra R Brave, Rajesh Odedra, Neil H James, Neil R Smith, Gayle B Marshall, Susan C Lovick

Int J Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of pretreatment with atenolol and nifedipine on ZD6126-induced cardiac toxicity in rats.
Sarah Gould, F Russell Westwood, Jon O Curwen, Susan E Ashton, David W Roberts, Susan C Lovick

J Natl Cancer Inst· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis